Biotech · Public company · South San Francisco, CA, US
Cero Therapeutics Holdings, Inc.
Ticker CERO · SEC CIK 0001870404
Track this companyFree. Adds Cero Therapeutics Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline4
- CER-1236Phase 1 · AMLClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · AMLClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · AMLClinicalTrials.gov · fetched Nov 12, 2026
- MesnaPhase 1 · AMLClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)PHASE1 · RECRUITING · started Apr 7, 2025ClinicalTrials.gov NCT06834282 · fetched Nov 12, 2026
SEC filings12
- 8-K · CURRENT REPORTSEC EDGAR · filed Oct 7, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Aug 31, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jul 17, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Jun 26, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
- 10-Q · QUARTERLY REPORTSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 10-K/A · AMENDMENT NO. 1 TO FORM 10-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 10-K · ANNUAL REPORTSEC EDGAR · filed Apr 15, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Apr 14, 2026 · fetched Nov 12, 2026
- 8-K · CURRENT REPORTSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026